Freeman Technology’s FT4 universal powder tester is being used by a team of Australian scientist. The technology is used to develop methods for improving the flow properties of
Schott announced at the Pharma Symposium in Mainz, Germany that it has started mass production of its TopLyo pharmaceutical packaging for lyophilized (freezedried) drugs at its Muellheim, Germany
Novartis has reported that its investigational vaccine, Menveo (Meningococcal Group A, C, W-135 and Y-CRM Conjugate Vaccine) has received a positive opinion from the Committee for Medicinal Products
Taro Pharmaceutical Industries (Taro) has initiated phase I clinical trials in Canada with T2007, the second in the company’s class of proprietary non-sedating barbiturate compounds to be approved
Cangene has received a positive opinion from the EMA’s Committee for Medicinal Products for Human Use (CHMP) regarding the immunoprophylaxis indication of its ImmunoGam (Human Hepatitis B Immunoglobulin).
Thallion Pharmaceuticals (Thallion) has signed a binding Letter of Intent (LOI) with LFB Biotechnologies (LFB) for the development of Shigamabs, Thallion’s product candidate for the treatment of Shiga
PolyMedix has completed the first two segments of a phase 1B clinical safety study with its antibiotic drug candidate, PMX-30063. PMX-30063 is small-molecule mimetic of host defense proteins
Amgen has received a positive opinion for the marketing authorisation of Prolia (denosumab) from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency
McNeil Consumer Healthcare (McNeil), division of McNEIL-PPC, has been expanding its voluntary recall to include all available product lots of Tylenol arthritis pain caplet 100 count bottles, with
The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to GlaxoSmithKline (GSK) for Revolade (Eltrombopag). The drug is aimed for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.